ImmunoFree Inc. Has Acquired Talaris Therapeutics, Inc.’s Tolerance Business; No Financial Terms Disclosed
ImmunoFree, Inc. announced today that it has acquired all right to FCR001, a cellular therapy product, and the sponsorship of the FREEDOM-1 Study formerly owned by Talaris Therapeutics (TALS). ImmunoFree has assumed all